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Carnosine (β-alanyl-L-histidine) has been shown 
to have an important role in the maintenance 
of homeostasis in the muscle cell due to the pH 
bu ering capabilities of the imidazole ring. As such, 
the expansion of the imidazole ring content in 
human skeletal muscle through an increase in the 
muscle carnosine concentration o ers a means to 
increase muscle bu ering capacity and high intensity 
exercise performance and capacity1-2. Other potential 
physiological roles of carnosine, such as increased 
calcium sensitivity3-4 and antioxidant capacity5-6 might 
also contribute to a positive e ect on exercise capacity 
and performance, although literature is inconclusive7. 
Carnosine is synthesised from the amino 
acids β-alanine and histidine, with β-alanine 
availability being rate limiting to the synthesis of 
the dipeptide within human skeletal muscle8. As 
a result, the dietary intake of β-alanine through 
supplementation is critical for the elevation in 
muscle carnosine content.  Most studies have used 
doses of between 3.2 and 6.4 g•d-1 of β-alanine, 
with this resulting in increases of 40 to 80% in the 
muscle carnosine concentration, depending upon 
the duration of supplementation and the method of 
determining the muscle carnosine content. 
Several reviews have concluded that there are 
signi" cant e ects of β-alanine supplementation on 
high-intensity exercise performance9-10. In particular, 
several studies have focussed on the effects of 
β-alanine supplementation on high intensity cycling 
capacity and have shown significant increases 
following supplementation11-13. The effects of 
β-alanine supplementation on cycling performance 
are more equivocal, with some showing no e ect14 
and others a signi" cant improvement15.  
Whilst there is general consensus in the literature 
for a bene" cial e ect of β-alanine supplementation 
on high intensity exercise performance9-10,16-17 fewer 
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Abstract
The effects of β-alanine supplementation on high-intensity cycling performance and capacity have 
been evaluated, although the effects on longer duration cycling performance are unclear. Nineteen UK 
category 1 male cyclists completed four 20 km cycling time trials, two before and two after supple-
mentation with either 6.4 g•d-1 β-alanine (n = 10; BA) or a matched placebo (n = 9; P). Performance 
time for the 20 km time trial and 1 km split times were recorded. There was no signiﬁ cant effect of 
β-alanine supplementation on 20 km time trial performance (BA-pre 1943 ± 129 s; BA-post 1950 ± 
147 s; P-pre 1989 ± 106 s; P-post 1986 ± 115 s) or on the performance of each 1 km split. The effect 
of β-alanine on 20 km time trial performance was deemed unclear as determined by magnitude based 
inferences. Supplementation with 6.4 g•d-1 of β-alanine for 4 weeks did not affect 20 km cycling time 
trial performance in well trained male cyclists.
KEY WORDS: Carnosine; Endurance exercise; Exercise test reability.
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studies have examined the e ects on longer duration 
exercise performance. However, a recent study 
examined the e ects of β-alanine supplementation on 
cycling performance in a time trial lasting ~ 1 hr18.  e 
" ndings suggest that despite marked increases in muscle 
carnosine concentration, β-alanine supplementation 
did not improve cycling performance18. 
However, Stout et al.19 supplemented untrained 
males with β-alanine and showed a 14.5% increase 
in physical working capacity at fatigue threshold post 
supplementation, while those supplementing with 
placebo decreased their physical working capacity at 
fatigue threshold by 1.8%. Furthermore, in a graded 
exercise test lasting ~19 minutes using untrained 
female participants, Stout et al.20 reported no e ects 
of β-alanine on maximal oxygen consumption but 
did report an increase in the time to exhaustion, as 
well as a delay in the onset of neuromuscular fatigue 
and an increase in the ventilatory threshold at 
submaximal workloads.  ese " ndings indicate the 
potential for β-alanine supplementation to increase 
performance during endurance based exercise.  It is 
important to note, however, that increases in power 
output at ventilatory threshold with β-alanine 
supplementation could also be caused by increased 
bu ering capacity, rather than other purported 
mechanisms, since higher bu ering capacity via 
Method
Participants
carnosine could reduce the need for H+ bu ering 
through hyperventilation and CO
2
 elimination.
Interestingly, some evidence also exists to suggest 
that an increase in muscle carnosine concentration 
could in' uence muscle " bre function in humans3. 
Dutka et al.3 mechanically skinned single muscle 
" bres taken from the “m. vastus lateralis” by muscle 
biopsy and subsequently characterised their calcium 
release and contractile properties.  ey showed that 
an increase in muscle carnosine content increased 
calcium sensitivity in slow and fast twitch muscle " bres 
and enhanced calcium release in slow twitch " bres. In 
addition Everaert et al.4 showed that providing mice 
with water containing 1.2% β-alanine for 8 weeks 
resulted in a higher carnosine concentration in the 
“extensor digitorum longus” and the “tibialis anterior”, 
and an increase in fatigue resistance in the soleus.
Taken together, the results of these investigations 
provide a potential mechanism by which an increase 
in the muscle carnosine content could confer 
bene" ts to exercise performances lasting longer 
than the 60-240 s mostly studied to date, for which 
increased muscle bu ering capacity would seem the 
most likely mechanistic explanation.   erefore, we 
aimed to examine the e ects of 4 weeks of β-alanine 
supplementation at 6.4 g•d-1 on 20 km cycling time 
trial performance in trained cyclists.
Twenty-six UK category 1 male cyclists, completing 
at least 7 hours of cycle training per week, volunteered 
to participate in the study that was conducted from 
April 2012 to June 2013, meaning participants 
were recruited throughout all phases of an annual 
training cycle.  ey were randomly assigned to either 
Participants were fully informed of any risks 
and discomforts associated with the study before 
completing a health screen and providing written 
a placebo (P) or β-alanine (BA) supplementation 
group; however, seven participants (4 from P and 
3 from BA) withdrew, citing various reasons not 
associated with the study. As such, 19 participants 
completed all trials; participant characteristics are 
presented in TABLE 1.  e study was approved by 
the Institution’s Ethical Advisory Committee and 
conformed to the Declaration of Helsinki.
TABLE 1 - Participant characteristics.
N Age (y) Height (m) Body mass (kg) Familiarisation(s)
β-alanine 10 37 ± 8 1.82 ± 0.06 78.7 ± 8.8 1975 ± 173
Placebo 9 32 ± 6 1.81 ± 0.04 80.4 ± 8.3 1993 ± 95
P value 0.211 0.902 0.671 0.786
informed consent. Participants had not taken any 
supplement in the three months prior to the study 
and had not taken β-alanine for at least six months 
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 is was a randomised, double-blind, placebo-
controlled, parallel groups design experiment. 
Subsequent to preliminary testing, participants 
completed two baseline trials (separated by 48 h) and 
two follow-up trials (separated by 48 h), separated by 
four weeks of supplementation with either placebo or 
β-alanine. Participants in BA ingested two sustained-
release tablets (CarnoSynSR, Natural Alternatives 
International, USA) each containing 800 mg of 
β-alanine (total dose per serving was 1.6 g) four times 
per day, separated by 3-4 h intervals, for a total daily 
dose of 6.4 g.  e total amount of β-alanine ingested 
over the 4 week period was 179.2 g. Participants in P 
ingested a matched placebo containing maltodextrin. 
Double blinding was ensured as both beta-alanine and 
placebo tablets were given to participants in identical 
white tubs. An experimenter not directly involved 
in participant testing noted the lot number of each 
bottle and then removed the lot number prior to 
administration to participants. Once data collection 
was complete, the supplement corresponding to each 
lot number was revealed.  
 e sustained-release formulation of β-alanine 
used in the present study has been shown to reduce 
the symptoms of paraesthesia often associated with 
individual doses of β-alanine administered as free 
powder22. In this study, none of the participants 
reported any feelings of paraesthesia, and we are 
con dent that the integrity of the double blinding 
was maintained. β-alanine tablets were tested by 
the manufacturer prior to release for the study and 
conformed to the label claim for β-alanine content. 
All supplements were independently tested by 
HFL Sports Science, UK, prior to use to ensure no 
contamination with steroids or stimulants according 
to ISO 17025 accredited tests.
Experimental design
Experimental protocol
Height (Seca, UK) and body mass (Seca, UK) 
were recorded before participants completed a full 
habituation test of the 20 km cycling time trial as 
described below. Following preliminary assessment, 
participants completed four identical main trials. 
All trials were completed at least 2 h postprandial 
following 24 h dietary standardisation, and 
participants had not completed vigorous exercise 
in the 24 h prior to each trial.  
Upon arrival at the laboratory, a capillary  nger 
prick blood sample was taken for the determination 
of baseline blood lactate concentration (2300 STAT 
Plus, YSI Ltd, UK). Participants then completed a 
self-paced  ve minute warm up on their bike followed 
by a three minute period of self-selected stretching 
before starting the 20 km time trial.  e time trial was 
completed on a Cyclus2 (RBM Electronic, Germany) 
ergometer on which the participants mounted their 
own bike frames.  e settings on the Cyclus2 were 
adjusted for each individual bike by entering the 
size of the front and back cog, bike weight and the 
crank length, ensuring an accurate measurement of 
distance and performance. During the exercise trial, 
the participant was deprived of any information 
regarding performance (e.g., time, speed, cadence) 
other than distance covered and gear selection and 
no feedback or encouragement was provided by 
experimenters. Participants were allowed to consume 
water ad libitum during exercise. Heart rate (T31 
system, Polar, Finland) was recorded after every 1 km 
interval and RPE (using the Borg 6-20 scale23) after 
every 5 km interval. Cycling performance data (e.g., 
time, distance, speed and cadence) was recorded by 
the Cyclus2 every 0.5 seconds. Immediately upon 
completion of the 20 km time trial and then again 
following a self-paced cool down, capillary  nger 
prick blood samples were taken for the determination 
of blood lactate concentration. Participants also 
performed three cognitive function tests (Stroop test, 
Sternberg paradigm and Rapid Visual information 
Processing (RVIP) task) before and after each 20 
km time trial to assess selective attention, working 
memory, and sustained attention. However, these 
data are presented elsewhere and only the exercise 
performance aspects of the study are presented here.
In order to determine the reliability of the 20 km 
time trial, we used the data from trials 1 and 2 on 
21 participants (age 35 ± 8 y, height 1.82 ± 0.05 
prior to the study due to the long washout period 
for muscle Carnosine21. Participants verbally agreed 
to maintain similar levels of physical activity and 
dietary intake for the duration of the study and 
compliance with this request was verbally con rmed 
with participants prior to each testing session. None 
of the cyclists were vegetarian and so would have 
ingested small amounts of dietary β-alanine from 
the hydrolysis of carnosine and methyl derivatives 
of this in meat.  is would typically be expected to 
be around 50 to 400 mg per day.
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Results
Statistical methods
m, body mass 80.7 ± 9.0 kg) who completed the 
20 km time trial as described above.  ere was no 
signi cant di erence in the time taken to complete 
the 20 km between trials 1 and 2 (trial 1: 1969 ± 112 
s; trial 2: 1975 ± 119 s; p = 0.222).  e intra-class 
correlation between trials 1 and 2 was r = 0.99, with 
the coe  cient of variation being 0.7%.
All data were checked for normality of distribution 
using the Shapiro-Wilk test. Data were analysed 
using unpaired t-tests between groups where there 
was only one time point. Mixed model ANOVA 
was employed in SPSS v20 to examine di erences 
in 20 km time trial performance, 1 km split times, 
blood lactate, heart rate and rating of perceived 
exertion between groups and across time and trials. 
Di erences between trials 1 and 2 and trials 3 
and 4 within groups were examined using paired 
t-tests. Where no differences were shown, the 
data from trials 1 and 2 were combined and the 
mean used as the pre-supplementation value and 
the data from trials 3 and 4 were combined and 
 ere was no main e ect of trial across the four 
trials (p = 0.649) or of supplementation between 
the BA and P groups (p = 0.484) for 20 km time 
trial performance.  ere was also no interaction 
e ect (p = 0.624).
Using paired t-tests and magnitude based inferences 
there were no di erences between trials 1 and 2 and 
trials 3 and 4 in BA (p = 0.463, unclear; p = 0.130, 
unclear) or P (p=0.537, unclear; p = 0.967, unclear). 
 erefore, the data from trials 1 and 2 were combined 
and the mean used as the pre-supplementation value 
and trials 3 and 4 were combined and the mean used 
as the post-supplementation value.
 ere was no main e ect of trial across the pre- 
and post- supplementation trials (p = 0.795) or of 
supplementation between the BA and P groups (p 
= 0.484) for 20 km time trial performance.  e 
the mean used as the post-supplementation value. 
Statistical signi cance was set at p ≤ 0.05 and data 
are presented as mean ± 1SD unless otherwise stated.
Time trial performance data were also analysed 
using a contemporary magnitude-based inferences 
approach24 in order to detect small effects of 
practical importance in an applied setting, a 
technique which is becoming increasingly common 
in exercise performance research.  is technique 
establishes the likelihood of an intervention having 
a positive/ trivial/ negative e ect. A Cohen’s unit of 
0.2 was employed as the smallest meaningful change 
in performance. Where the chance of both a positive 
and negative e ect is > 5%, the e ect is deemed 
unclear. Qualitative descriptors were assigned to the 
quantitative percentile scores as follows: 25-75% 
possible; 75-95% likely; > 99% almost certain25-26. 
For determination of the magnitude based e ects, 
we chose to average trials 1 and 2 and trials 3 and 4 
within each group. We then calculated the di erence 
between pre- and post- supplementation in each 
group, with the magnitude of the e ect of β-alanine 
supplementation being determined as the di erence 
between the two groups.
Performance data mean performance time for the BA group was 1943 
± 129 s pre-supplementation and 1950 ± 147 s 
post-supplementation, while for the P group this 
was 1989 ± 106 s pre-supplementation and 1986 
± 115 s post supplementation.  ere was also no 
interaction e ect (p = 0.575).
 e magnitude of the e ect of supplementation 
in the BA group was unclear (p = 0.556), as was 
the e ect of supplementation in the P group (p 
= 0.847). Finally, the di erence between the two 
groups, and therefore the magnitude of the e ect 
of β-alanine supplementation, was also deemed 
unclear (p = 0.575).
With regard to individual responses to 
supplementation, in the BA group  ve participants 
improved with supplementation, one stayed the 
same and four became slower. In the P group, four 
participants became slower and  ve participants 
improved (FIGURE 1).
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TABLE 2 - Heart rate (beats•min-1) and rating of perceived exertion (6-20) at 5 km intervals during the 20 km 
time trial and lactate concentration before and after the 20 km time trial (mmol•L-1).
Supporting data
 ere was a signi cant e ect of exercise on heart rate 
(p < 0.001) and rating of perceived exertion (p < 0.001), 
β - a l a n i n e  ( B A ) 
(▬▬▬);
Placebo (P) (▬    ▬).
Individual 20 km time trial performances pre- and post- supplementation in β-alanine (BA) and 
Placebo (P).
FIGURE 1 -
which both increased over the 20 km time trial. However, 
there was no e ect of trial and no di erence between the 
groups for either heart rate (p = 0.520; p = 0.958) or rating 
of perceived exertion (p = 0.240; p = 0.396; TABLE 2).
Distance 
(km)
Pre-supplementation Post-supplementation
5 10 15 20 5 10 15 20
Heart 
rate
β-alanine 154 ± 8 157 ± 10 160 ± 11 171 ± 8 155 ± 6 159 ± 8 163 ± 10 173 ± 10
Placebo 153 ± 10 159 ± 7 162 ± 8 175 ± 7 156 ± 12 161 ± 9 162 ± 10 177 ± 8
RPE
β-alanine 15 ± 2 16 ± 1 17 ± 1 19 ± 1 15 ± 2 16 ± 1 17 ± 1 18 ± 1
Placebo 14 ± 1 16 ± 1 17 ± 1 19 ± 1 14 ± 1 16 ± 1 17 ± 1 19 ± 1
Pre-supplementation Post-supplementation
Pre-TT Post-TT Pre-TT Post-TT
Lactate
β-alanine 1.32 ± 0.49 10.04 ± 1.90 1.55 ± 0.56 9.49 ± 2.32
Placebo 1.26 ± 0.60 9.81 ± 2.24 1.39 ± 0.67 9.64 ± 1.80
Due to di"  culties with the Cyclus2 saving split data 
in some trials, 1 km splits are given for n = 7 in BA and 
n = 7 in P.  ere was a signi cant e ect of time on 1 
km splits, with split times becoming faster towards the 
end of the 20 km time trial.  ere was no di erence 
across the four trials or between the two groups for 1 
km split times (p = 0.630; p = 0.760; FIGURE 2). 
Finally, blood lactate concentrations increased due to 
the exercise (p < 0.001) but again there was no e ect 
of trial or group (p = 0.093; p = 0.869; TABLE 2).
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Discussion
This is the first study to examine the effects 
of β-alanine supplementation on 20 km time 
trial performance in well trained male cyclists, 
demonstrating no signi cant e ect of β-alanine 
supplementation on this model of exercise 
performance. # e individual data is also supportive 
of a lack of β-alanine supplementation on time trial 
performance, with equal numbers of participants 
showing increased and decreased performance; with 
all changes being relatively marginal in any case. 
In an attempt to detect small e ects of practical 
importance we also determined the magnitude 
based inferences. In line with the  nding of no 
signi cant e ect, the magnitude of the e ect of 
β-alanine supplementation on 20 km time trial 
performance was unclear. As such, and given 
the high degree of reliability of the performance 
test used in this study (test-retest data having a 
CV of 0.7%), we can be con dent in the lack of 
an e ect of β-alanine on this performance test. 
# ese  ndings are also in accordance with those of 
Chung et al.18, demonstrating no e ect of β-alanine 
supplementation on ~ 1 hour cycling time trial 
performance. # us, these  ndings suggest that despite 
the bene cial e ects of β-alanine supplementation 
on high intensity exercise capacity9-10, β-alanine 
supplementation does not in+ uence longer duration 
(30 min - 1 hr), lower intensity, cycling performance.
An inherent problem of time trial tests in well 
trained participants who are familiar with the 
exercise protocol is that they are in+ uenced by 
pacing strategies27 and sometimes these pacing 
strategies do not produce optimal performance28. 
# ere is also a variety, possibly an in nite number, 
of pacing strategies available to an individual29. 
However, if pacing strategies were employed by 
the athletes in the present study variables such as 
heart rate, blood lactate and particularly the RPE 
responses to exercise would have been lower in the 
group supplemented with β-alanine. Although, as 
expected, exercise increased heart rate, lactate and 
RPE, β-alanine supplementation exerted no e ect 
on any parameter during exercise, indicating that 
this is unlikely to have been the case.
We hypothesised that β-alanine supplementation 
would improve time trial performance given the 
previously reported in+ uence of β-alanine on the 
ventilatory threshold20 and the potential for an 
increase in muscle carnosine to increase the calcium 
sensitivity of slow and fast twitch muscle  bres 
and enhance calcium release in slow twitch  bres3. 
However, the strength of the currently available 
evidence to support the e ects of carnosine on 
calcium handling is limited2,9, with only one study3 
being conducted on human muscle  bres. If calcium 
handling were the main mechanism for an e ect of 
FIGURE 2 - 1 km split times for the mean pre- (  ) and post- (□) supplementation trials in β-alanine (BA) and 
mean pre- (●) and post- (□) supplementation trials in Placebo (P). 
The effects of β-alanine 
supplementation on hi-
gh-intensity cycling per-
formance and capacity 
have been evaluated, 
although the effects on 
longer duration cycling 
performance are un-
clear. Nineteen UK ca-
tegory 1 male cyclists 
completed four 20 km 
cycling time trials, two 
before and two after 
supplementation with 
either 6.4 g•d-1 β-alanine 
(n = 10; BA) or a ma-
tched placebo (n = 9; 
P). Performance time for 
the 20 km time trial and 
1 km split times were 
recorded. There was 
no signiﬁ cant effect of 
β-alanine supplementa-
tion on 20 km time trial 
performance (BA-pre 
1943 ± 129 s; BA-post 
1950 ± 147 s; P-pre 
1989 ± 106 s; P-post 
1986 ± 115 s) or on the 
performance of each 
1 km split. The effect 
of β-alanine on 20 km 
time trial performance 
was deemed unclear as 
determined by magni-
tude based inferences. 
Supplementation with 
6.4 g•d-1 of β-alanine for 
4 weeks did not affect 20 
km cycling time trial per-
formance in well trained 
male cyclists.
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elevated muscle carnosine on exercise performance, 
signi cant e ects of β-alanine supplementation 
would be expected across a wider range of exercise 
performance tests than have currently been shown2,9. 
Whilst the present study was not designed to 
examine the mechanisms related to increased 
exercise performance as a result of elevated muscle 
carnosine levels, the lack of an e ect of β-alanine 
would be consistent with the lack of an e ect of 
carnosine on calcium handling. Either that or 
alterations to calcium sensitivity or release do not 
in! uence 20 km time trial performance.  
Taking the existing evidence as a whole, the 
most likely mechanism for an e ect of increased 
muscle carnosine on exercise performance and 
capacity remains the e ect it has on intracellular 
pH bu ering. Lending support to this assertion, 
studies have examined the e ects of β-alanine on 
exercise capacity, using tests designed to induce 
large increases in intramuscular hydrogen cation 
levels and reductions in pH11-12,30, and have shown 
signi cant increases in exercise capacity. In relation 
to cycling, studies have shown signi cant e ects 
of β-alanine supplementation on high-intensity 
cycling capacity, as determined by increases in total 
work done11-12. " e cycling capacity test at 110% of 
powermax used by both of these studies is one of the 
few tests to be independently repeated with β-alanine 
supplementation. " e increase in cycling capacity 
reported following 4 weeks of supplementation was 
similar in both studies; Hill et al.11 reported an 
increase of 13% and Sale et al.12 an increase of 15% 
using a slightly higher total intake of β-alanine. " e 
fact that reductions in intracellular pH are unlikely 
to be limiting to 20 km time trial performance might 
thus help to explain the lack of a signi cant e ect 
in the present study. However, during competitive 
cycling inclines in the road surface will frequently 
be encountered, with trials typically ending in a 
sprint, both of which might be expected to reduce 
intramuscular pH. It is therefore possible that 
increased muscle carnosine levels brought about by 
β-alanine supplementation may improve endurance 
cycling performance in real-life competitive races.
" at said, not all studies with regards to high-
intensity cycling performance tests have shown 
signi cant e ects of β-alanine supplementation. 
Bellinger et al.14 reported no e ect of β-alanine 
supplementation on maximal 4 minute cycling 
performance, although van Thienen et al.15 
reported a signi cant e ect of β-alanine on 30 s 
isokinetic sprint cycling, performed at the end of 
a 110 min simulated endurance cycle race. Due 
to the  ndings of van Thienen et al.15, we also 
determined the 1 km split times in the current study 
to ascertain whether there was any e ect of β-alanine 
supplementation on exercise performance towards 
the end of the 20 km time trial. Split times were 
relatively consistent throughout but did become 
faster towards the end of the 20 km time trial in 
both groups, particularly in the  nal kilometre. 
However, there was no e ect of β-alanine on the 
performance of any 1 km split.
" e present study is not without its limitations; 
it should be noted that we did not determine the 
in! uence of β-alanine supplementation on muscle 
carnosine concentrations. " is was primarily due to 
the lack of availability of a non-invasive method of 
determining muscle carnosine content in these well-
trained participants. As such, we cannot con rm in 
the present study that muscle carnosine contents were 
signi cantly increased and, if so, what the magnitude 
of this increase was.  However, supplementation with 
β-alanine at this level has consistently been shown 
to increase muscle carnosine concentrations by over 
60%8,11, with others reporting no non-responders to 
β-alanine supplementation11,21,31. Indeed, only one 
participant from the series of muscle studies to-date 
has failed to respond to β-alanine supplementation 
with an increase in muscle carnosine8. Overall 
increases have been shown to be between 40 and 
80% depending upon dose (between 3.2 and 6.4 
g•d-1) and duration of administration (between 4 
and 10 weeks). Furthermore, based on the dose-
response relationship shown by Stellingwerff 
et al.32, our supplementation regimen would be 
expected to result in a 3.6 mmol•kg
ww
-1 increase in 
muscle carnosine concentration.
Practical applications
" ese data suggest that endurance cyclists competing 
in events lasting around 30 minutes will not bene t 
from β-alanine supplementation. However, it may be 
that when the intensity of the cycling is increased, for 
example during a hill climb or a sprint  nish, enhanced 
intramuscular H+ buffering, through β-alanine 
supplementation, may be bene cial to performance. 
Future research should investigate this possibility.
In conclusion, supplementation with 6.4 g•d-1 of 
β-alanine for 4 weeks did not a ect 20 km cycling 
time trial performance in well trained male cyclists. 
" is might suggest that a mechanism to support 
an e ect for β-alanine supplementation on longer 
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